3645 results for «566»
3645 results
TAVI interventions for all? From congenital bicuspid valve towards valve-in-valve challenging cases
21 May 2026 – From EuroPCR 2026
This session delves into the complexities of TAVI interventions across diverse challenging cases, including congenital bicuspid valves and valve-in-valve scenarios. It emphasizes complication prevention, decision-making for the Unicorn technique, and the critical role of pre-procedural imaging, illustrated through detailed case studies from Estonia, the Netherlands, and...
Antithrombotic strategies in challenging clininal scenarios
21 May 2026 – From EuroPCR 2026
This session presents a comprehensive overview of antithrombotic strategies tailored to challenging clinical scenarios. Topics include management in elderly patients with atrial fibrillation undergoing DES implantation, the use of low-dose Cangrelor and Bivalirudin during PCI under ECMO in cardiac arrest, polymer types in stents, and timing...
Complication two: PCI complications occurring during PCI for NSTEMI
21 May 2026 – From EuroPCR 2026
This session addresses the spectrum of PCI complications encountered during NSTEMI interventions, including coronary perforations, challenges with unexpanded covered stents, IVUS-related issues, giant coronary aneurysms at bifurcations, and distal wire perforations, providing critical lessons in complication management and operator coordination.
New insights in coronary atherosclerosis using intracoronary imaging
21 May 2026 – From EuroPCR 2026
This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
